Immediate adverse events following COVID-19 immunization. A cross-sectional study of 314,664 Italian subjects

BACKGROUND AND AIM: The urgency of having rapidly safe and efficient COVID-19 vaccines called for the need to shorten trial phases, reduce sample sizes, and speed-up the approval process by the regulatory Agencies. In light of this, monitoring adverse effects (AEFI) (both immediate and at medium-lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Gianfredi, Vincenza, Minerva, Massimo, Casu, Giulia, Capraro, Michele, Chiecca, Greta, Gaetti, Giovanni, Mantecca Mazzocchi, Rosaria, Musarò, Patrizia, Basteri, Paola, Bertini, Beatrice, Ferri, Camilla, Odone, Anna, Signorelli, Carlo, Alberti, Valerio Fabio, Gastaldi, Gilda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2021
Materias:
Original Investigations/Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851022/
https://www.ncbi.nlm.nih.gov/pubmed/34739452
http://dx.doi.org/10.23750/abm.v92iS6.12365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8851022/
https://www.ncbi.nlm.nih.gov/pubmed/34739452
http://dx.doi.org/10.23750/abm.v92iS6.12365

Ejemplares similares